ÂÜŔňÂŇÂ×

Dr James McIlroy is a qualified medical doctor and biopharmaceutical entrepreneur that is widely recognised as a pioneer and thought leader in the application of the microbiome to treat disease.

James Founded EnteroBiotix with the vision of building one of the world’s leading microbiome drug development companies. As CEO, James combines his medical, business and scientific expertise to effectively lead the Company’s drug development programmes.

James holds a BMedSci (Hons) from the University of Edinburgh and an MBChB (with distinction) from the University of Aberdeen.

James is a named inventor on several microbiome related patent applications and has been published as first author in journals such as Alimentary Pharmacology & Therapeutics, Frontline Gastroenterology and Clinical Immunology.